Back to Search Start Over

Oncology Drug Reference Sheet: Elacestrant.

Authors :
Dickman, Erin
Source :
ONS Voice. 7/6/2023, p1-1. 1p.
Publication Year :
2023

Abstract

The article provides information on elacestrant, an estrogen receptor (ER) antagonist which was granted by the U.S. Food and Drug Administration an application priority review and fast-track designation, with regular approval in January 2023. Topics discussed include dosing and administration, adverse reactions, and nursing considerations.

Details

Language :
English
ISSN :
24756938
Database :
Academic Search Index
Journal :
ONS Voice
Publication Type :
Academic Journal
Accession number :
182075290